We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

4887:TSESAWAI GROUP HOLDINGS Co., Ltd. Analysis

Data as of 2026-03-15 - not real-time

¥2,127.00

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Sawai Group is trading at ¥2,127, which sits below its 20‑day (¥2,265.7) and 50‑day (¥2,339.2) moving averages, indicating short‑term weakness, yet it remains above the 200‑day average (¥2,043.3), suggesting a neutral longer trend. Technical signals are mixed: the RSI of 31 points to oversold conditions and a potential bounce near the identified support level of ¥2,085, while a bearish MACD histogram reinforces downside pressure. On the valuation side, the trailing P/E of 21.98 is comfortably under the industry average of 26.18, and a forward P/E of 12.43 hints at earnings acceleration, but a discounted cash‑flow model flags a fair value around ¥1,103, implying the market may be pricing in a significant premium. Fundamentally, the company delivers a 2.59% dividend yield with a 55% payout ratio, supported by ample cash reserves (¥46.6 bn) despite a high debt load (¥122.5 bn) and a debt‑to‑equity ratio of 68.5, which raises concerns about leverage and sustainability. Recent Q3 earnings call material did not reveal major surprises, and the stock’s volatility of 25.6% over 30 days combined with a low beta of 0.16 suggests price swings are largely company‑specific rather than market‑driven. Overall, the blend of modest valuation upside, attractive dividend, and elevated financial risk creates a nuanced investment case.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near technical support at ¥2,085
  • Oversold RSI suggesting limited downside
  • Bearish MACD indicating continued pressure

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Trailing P/E below industry average
  • Forward P/E of 12.4 implying earnings growth
  • Attractive 2.59% dividend yield with moderate payout

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • High debt‑to‑equity ratio and negative free cash flow
  • DCF fair value far below current price
  • Stable sector demand offset by regulatory and leverage risks

Key Metrics & Analysis

Financial Health

Revenue Growth1.20%
Profit Margin4.10%
P/E Ratio22.0
ROE-0.67%
ROA2.59%
Debt/Equity68.51
P/B Ratio1.4
Op. Cash Flow¥20.3B
Free Cash Flow¥-1034124992
Industry P/E26.2

Technical Analysis

TrendNeutral
RSI31.2
Support¥2,085.00
Resistance¥2,407.00
MA 20¥2,265.70
MA 50¥2,339.19
MA 200¥2,043.30
MACDBearish
VolumeDecreasing
Fear & Greed Index72.88

Valuation

Fair Value¥1,102.97
Target Price¥2,666.67
Upside/Downside25.37%
GradeFair
TypeBlend
Dividend Yield2.59%

Risk Assessment

Beta0.17
Volatility25.58%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.